Co-Authors
This is a "connection" page, showing publications co-authored by Detlef Kindgen-Milles and Torsten Feldt.
Connection Strength
0.571
-
Informed consent and informed intervention: SARS-CoV-2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing. Eur J Med Res. 2021 Aug 06; 26(1):87.
Score: 0.060
-
Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany. Lancet Reg Health Eur. 2021 Sep; 8:100164.
Score: 0.060
-
Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial. Trials. 2021 May 17; 22(1):343.
Score: 0.059
-
Prolonged Neuropsychological Deficits, Central Nervous System Involvement, and Brain Stem Affection After COVID-19-A Case Series. Front Neurol. 2020; 11:574004.
Score: 0.057
-
Correction to: The role of passive immunization in the age of SARS-CoV-2: an update. Eur J Med Res. 2020 Oct 30; 25(1):53.
Score: 0.057
-
Measures of infection prevention and incidence of SARS-CoV-2 infections in cancer patients undergoing radiotherapy in Germany, Austria and Switzerland. Strahlenther Onkol. 2020 12; 196(12):1068-1079.
Score: 0.056
-
Face masks: benefits and risks during the COVID-19 crisis. Eur J Med Res. 2020 Aug 12; 25(1):32.
Score: 0.056
-
The history and value of face masks. Eur J Med Res. 2020 Jun 23; 25(1):23.
Score: 0.056
-
Genetic structure of SARS-CoV-2 reflects clonal superspreading and multiple independent introduction events, North-Rhine Westphalia, Germany, February and March 2020. Euro Surveill. 2020 Jun; 25(22).
Score: 0.055
-
The role of passive immunization in the age of SARS-CoV-2: an update. Eur J Med Res. 2020 May 13; 25(1):16.
Score: 0.055